×
About 4,878 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  1,544 results

Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment ...
https://doi.org/10.1111/jdv.18632
Journal of the European Academy of Dermatology and Venere... Tzellos T, van Straalen KR et. al.

Oct 4th, 2022 - Validated, inclusive, and easy-to-use outcomes for HS are essential both in the clinical trial setting and clinical practice. The continuous IHS4 is a validated tool that dynamically assesses nodules/abscesses/draining tunnels and classifies disea...

African American race is a risk factor for severe hidradenitis suppurativa.
https://doi.org/10.1111/ijd.16428
International Journal of Dermatology; Ulschmid C, Serrano L et. al.

Oct 3rd, 2022 - African Americans face a disproportionate incidence and prevalence of hidradenitis suppurativa (HS) in the United States, but HS severity and outcomes across racial and ethnic groups have not been well-established while controlling for potentially...

Hidradenitis suppurativa.
https://doi.org/10.12788/jfp.0410
The Journal of Family Practice; Heath CR, Usatine RP

Oct 1st, 2022 - THE COMPARISONSevere longstanding hidradenitis suppurativa (Hurley stage III) with architectural changes, ropy scarring, granulation tissue, and purulent discharge in the axilla of A 35-year-old Black man. A 42-year-old Hispanic woman with a light...

A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
https://clinicaltrials.gov/ct2/show/NCT05348681

Sep 30th, 2022 - A Randomized, Double-blinded, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Hidradenitis Suppurativa

Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis su...
https://doi.org/10.1111/dth.15866
Dermatologic Therapy; Burzi L, Repetto F et. al.

Sep 30th, 2022 - Adalimumab is the only biological drug approved to date for the treatment of moderate and/or severe hidradenitis suppurativa. Adverse events reported during therapy include paradoxical psoriasiform reactions. No guidelines are currently available ...

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  141 results

A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
https://clinicaltrials.gov/ct2/show/NCT05348681

Sep 30th, 2022 - A Randomized, Double-blinded, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Hidradenitis Suppurativa

Hidradenitis Suppurativa Patient Experience With Humira Treatment
https://clinicaltrials.gov/ct2/show/NCT04132388

Sep 29th, 2022 - This is a prospective single-center open-label randomized 6 month study. There will not be a washout period. Treatment will be for 26 weeks. Subjects will have baseline disease severity assessments. Subjects will be instructed to take adalimumab a...

Hidradenitis Suppurativa Phase 2b Pivotal Study of Izokibep
https://clinicaltrials.gov/ct2/show/NCT05355805

Sep 28th, 2022 - Izokibep is a potent and selective inhibitor of interleukin 17A (IL-17A) that is being developed for treatment of hidradenitis suppurativa (HS). This study will evaluate the efficacy, safety, and immunogenicity of izokibep administered subcutaneou...

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04988308

Sep 28th, 2022 - Hidradenitis suppurativa (HS) is a chronic skin disease of unclear etiology that affects 1 percent (%) to 4% of the general population. JNJ-77474462 (bermekimab) is a recombinant human immunoglobulin G1 kappa (IgG1k) monoclonal antibody (mAb) that...

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT03827798

Sep 28th, 2022 - The main purpose of this study is to assess preliminary efficacy and safety of CFZ533, LYS006, MAS825 and LOU064 in patients with moderate to severe hidradenitis suppurativa and to determine if CFZ533, LYS006, MAS825 and LOU064 have an adequate cl...

see more →

News  256 results

Hope Shines Bright for Hidradenitis Suppurativa Treatments
https://www.medscape.com/viewarticle/980925

Sep 16th, 2022 - Additional hidradenitis suppurativa (HS) treatments could be on the horizon with the news that both secukinumab and the investigational drug brepocitinib reduced the effects of the chronic and painful skin condition in separate trials. Around 40%-...

Surgical Deroofing for Hidradenitis Suppurativa
https://www.mdedge.com/dermatology/article/257714/autoimmune-diseases/surgical-deroofing-hidradenitis-suppurativa
Devin Allison, MD, Jessica Sterner, MD et. al.

Sep 12th, 2022 - Practice Gap Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by inflammatory nodules, abscesses, sinus tracts, fistulae, and scarring, mainly in intertriginous areas. The extent of disease—classified using the.

Multiple Eruptive Dermatofibromas Associated With Down Syndrome
https://www.mdedge.com/dermatology/article/257306/mixed-topics/multiple-eruptive-dermatofibromas-associated-down-syndrome
Timothy J. Zimmerman, MD, Saira J. George, MD

Aug 24th, 2022 - To the Editor: Dermatofibromas (also known as fibrous histiocytomas) are benign fibrous nodules that most often arise as solitary lesions on the lower extremities. Multiple eruptive dermatofibromas (MEDFs) are uncommon and have been defined as mor.

Does Hidradenitis Suppurativa Worsen During Pregnancy
https://www.medscape.com/viewarticle/979159

Aug 12th, 2022 - PORTLAND, Oregon — The recurrent boils, abscesses, and nodules of the chronic inflammatory skin condition hidradenitis suppurativa (HS) may improve during pregnancy for a subset of women, but for many, pregnancy does not change the disease course ...

Does hidradenitis suppurativa worsen during pregnancy?
https://www.mdedge.com/dermatology/article/256966/medical-dermatology/does-hidradenitis-suppurativa-worsen-during-pregnancy
Doug Brunk

Aug 11th, 2022 - PORTLAND, ORE. – The recurrent boils, abscesses, and nodules of the chronic inflammatory skin condition hidradenitis suppurativa (HS) may improve during pregnancy for a subset of women, but for many, pregnancy does not change the disease course an.

see more →

Patient Education  8 results see all →